Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2023 | 2 |
2024 | 1 |
2025 | 0 |
Cited In for PMID: 37814449
3 results
Results by year
Filters applied: . Clear all
Page 1
Intravitreal injection of a rationally designed AAV capsid library in non-human primate identifies variants with enhanced retinal transduction and neutralizing antibody evasion.
Mol Ther. 2023 Dec 6;31(12):3441-3456. doi: 10.1016/j.ymthe.2023.10.001. Epub 2023 Oct 9.
Mol Ther. 2023.
PMID: 37814449
Free PMC article.
Engineered AAV capsid transport mutants overcome transduction deficiencies in the aged CNS.
Sandoval IM, Kelley CM, Bernal-Conde LD, Steece-Collier K, Marmion DJ, Davidsson M, Crosson SM, Boye SL, Boye SE, Manfredsson FP.
Sandoval IM, et al.
Mol Ther Nucleic Acids. 2024 Sep 12;35(4):102332. doi: 10.1016/j.omtn.2024.102332. eCollection 2024 Dec 10.
Mol Ther Nucleic Acids. 2024.
PMID: 39445231
Free PMC article.
Item in Clipboard
Bypassing pre-existing antibodies extends the applicability of AAV-based retinal therapies.
Hu HF, Tsang SH.
Hu HF, et al.
Mol Ther. 2023 Dec 6;31(12):3363. doi: 10.1016/j.ymthe.2023.11.005. Epub 2023 Nov 23.
Mol Ther. 2023.
PMID: 38000369
Free PMC article.
No abstract available.
Item in Clipboard
Cite
Cite
ARTICLE TYPE
ARTICLE LANGUAGE
AGE
Filters on the sidebar will be reset to the default list and any currently applied filters will be cleared.